D3 BIO INC
HQ - Shanghai
Summary
D3 Bio is a clinical-stage biotechnology company focused on oncology therapeutics, including KRAS inhibitors.
Deals Overview
Total Deals3
Valued Deals3
Total Value£ 264 M
Avg. Deal Size£ 88 M
All rights reserved. Copyright © 2026 Datasite
